Business Description
Kopran Ltd
ISIN : INE082A01010
Total Employee Number:
1,024Compare
Compare
Traded in other countries / regions
524280.India IPO Date
1999-06-09Description
Kopran Ltd is an Indian pharmaceutical company with integrated operations across formulations and Active Pharmaceutical Ingredients (APIs). The company is engaged in the development, manufacturing and marketing of pharmaceutical products for both domestic and international markets. Its formulations business focuses on oral solid dosage forms and other pharmaceutical products across a range of therapeutic categories. The API business manufactures a portfolio of APIs and intermediates. Its portfolio spans therapeutic areas such as anti-infectives, cardiovascular, gastroenterology, CNS and anti-diabetic products, along with specialized APIs including Atenolol and Sterile Carbapenems. It operates in a single reportable segment of the manufacturing of Formulation (Finished Dosage Form).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 2.45 | |||||
Interest Coverage | 5.77 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.2 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | -1.4 | |||||
3-Year FCF Growth Rate | 75.9 | |||||
3-Year Book Growth Rate | 6.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.54 | |||||
9-Day RSI | 39.99 | |||||
14-Day RSI | 45.63 | |||||
3-1 Month Momentum % | 14.99 | |||||
6-1 Month Momentum % | 47.84 | |||||
12-1 Month Momentum % | 17.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 1.04 | |||||
Days Inventory | 140.58 | |||||
Days Sales Outstanding | 114.12 | |||||
Days Payable | 104.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.57 | |||||
Dividend Payout Ratio | 0.56 | |||||
Forward Dividend Yield % | 1.57 | |||||
5-Year Yield-on-Cost % | 3.47 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.54 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.57 | |||||
Operating Margin % | 8.87 | |||||
Net Margin % | 3.78 | |||||
EBITDA Margin % | 9.14 | |||||
FCF Margin % | -0.05 | |||||
OCF Margin % | 9.8 | |||||
ROE % | 4.98 | |||||
ROA % | 3.01 | |||||
ROIC % | 6.54 | |||||
3-Year ROIIC % | 6 | |||||
ROC (Joel Greenblatt) % | 7.17 | |||||
ROCE % | 8.12 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 36.35 | |||||
PE Ratio without NRI | 36.35 | |||||
Shiller PE Ratio | 20.17 | |||||
Price-to-Owner-Earnings | 56.23 | |||||
PS Ratio | 1.37 | |||||
PB Ratio | 1.76 | |||||
Price-to-Tangible-Book | 1.84 | |||||
Price-to-Operating-Cash-Flow | 13.98 | |||||
EV-to-EBIT | 24.01 | |||||
EV-to-EBITDA | 17.28 | |||||
EV-to-Revenue | 1.58 | |||||
EV-to-FCF | -2861.56 | |||||
Price-to-GF-Value | 0.84 | |||||
Price-to-Projected-FCF | 3 | |||||
Price-to-Median-PS-Value | 1.12 | |||||
Price-to-Graham-Number | 1.71 | |||||
| Price-to-Net-Current-Asset-Value | 6.32 | |||||
Earnings Yield (Greenblatt) % | 4.16 | |||||
FCF Yield % | -0.04 | |||||
Forward Rate of Return (Yacktman) % | -11.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kopran Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,814.236 | ||
| EPS (TTM) (₹) | 5.32 | ||
| Beta | 1.4848 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.18 | ||
| Volatility % | 71.02 | ||
| 14-Day RSI | 45.63 | ||
| 14-Day ATR (₹) | 8.883709 | ||
| 20-Day SMA (₹) | 197.7085 | ||
| 12-1 Month Momentum % | 17.5 | ||
| 52-Week Range (₹) | 107 - 219 | ||
| Shares Outstanding (Mil) | 48.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kopran Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kopran Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 3.000000 Cash Dividend | 2026-08-11 | In 8 days | ||
| INR 3.000000 Cash Dividend | 2025-09-04 | 172.88 (+7.38%) | ||
| INR 3.000000 Cash Dividend | 2024-09-02 | 298.90 (+0.30%) |
Show
Entries
Kopran Ltd Frequently Asked Questions
What is Kopran Ltd(NSE:KOPRAN)'s stock price today?
The current price of NSE:KOPRAN is ₹191.03. The 52 week high of NSE:KOPRAN is ₹219.00 and 52 week low is ₹107.00.
When is next earnings date of Kopran Ltd(NSE:KOPRAN)?
The next earnings date of Kopran Ltd(NSE:KOPRAN) is .
Does Kopran Ltd(NSE:KOPRAN) pay dividends? If so, how much?
The Dividend Yield %  of Kopran Ltd(NSE:KOPRAN) is 1.57% (As of Today), Highest Dividend Payout Ratio of Kopran Ltd(NSE:KOPRAN) was 0.56. The lowest was 0.1. And the median was 0.35. The  Forward Dividend Yield % of Kopran Ltd(NSE:KOPRAN) is 1.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kopran Ltd
No articles.